Zdrowie i gospodarka · 27/10/1995
Drug Export; AVONEXSUPTM, Recombinant Interferon Beta-1a
The Food and Drug Administration (FDA) is announcing that Biogen, Inc., has filed an application requesting approval for the export of the human biological product AVONEX TM, Recombinant Interferon Beta-1a to the United Kingdom.
Source: Federal Register — Food and Drug AdministrationOpen original release →